Risk Analysis, Volume 45, Issue 12, Page 4619-4643, December 2025.Abstract Future pandemics could arise from several sources, notably, emerging infectious diseases (EID); and lab leaks from high containment biological laboratories (HCBL). Recent advances in infectious disease, information technology, and biotechnology provide building blocks to reduce pandemic risk if deployed intelligently.
Ross J. Tieman +2 more
wiley +1 more source
Complete protection for mice conferred by a DNA vaccine based on Japanese encephalitis virus P3 strain that is used to prepare the inactivated vaccine in China [PDF]
, 2020 Ran Wang +3 more
openalex +1 more source
Transfusion, Volume 65, Issue 12, Page 2236-2249, December 2025.Abstract Background Blood donors represent a unique population. Pre‐donation screening questions, donor self‐deferral, and temporary deferral and re‐testing of repeat reactive donors result in lower prevalence of infectious disease compared to the general population.
Carmen L. Charlton +3 more
wiley +1 more source
Identification and isolation of Genotype-I Japanese Encephalitis virus from encephalitis patients
Virology Journal, 2010 Historically, Japanese Encephalitis virus (JEV) genotype III (GIII) has been responsible for human diseases. In recent years, JEV genotype I (GI) has been isolated from mosquitoes collected in numerous countries, but has not been isolated from patients ...
Gao Xiaoyan +16 more
doaj +1 more source
Vaccines, 2020 This article aims to review the present status of anti-flavivirus subunit vaccines, both those at the experimental stage and those already available for clinical use.
Sergio C. Araujo +6 more
doaj +1 more source
Micro/Nanorobots for Combating Brain Disorders: Challenges, Advances, and Perspectives
Advanced Science, Volume 12, Issue 44, November 27, 2025.Micro/nanorobots (MNRs) offer a transformative approach for precision therapy in brain disorders. By overcoming biological barriers and enabling controlled propulsion, targeted delivery, and real‐time imaging/tracking, MNRs pave the way toward effective, minimally invasive treatments. This review outlines the interplay between brain disease challenges,
Qi Zhang, Dong Sun
wiley +1 more source
An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection [PDF]
, 2021 Tomoyoshi Komiya +3 more
openalex +1 more source
Health Science Reports, Volume 8, Issue 11, November 2025.ABSTRACT Background and Aims SARS‐CoV‐2 continues to pose global challenges, and current vaccines face limitations (variant escape, waning immunity). This review evaluates immunostimulatory adjuvants and nano‐adjuvants to enhance immune responses and optimize SARS‐CoV‐2 vaccine performance.
Peyman Kheirandish Zarandi +5 more
wiley +1 more source
Frontiers in ImmunologyVaccination remains the sole effective strategy for combating Japanese encephalitis (JE). Both inactivated and live attenuated vaccines exhibit robust immunogenicity. However, the production of these conventional vaccine modalities necessitates extensive
Takele Adugna +14 more
doaj +1 more source
Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. [PDF]
PLoS Negl Trop Dis, 2023 Sandberg JT +10 more
europepmc +1 more source